MedTrace Logo

A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery

NCT02302794 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1056

Last updated 2014-11-27

No results posted yet for this study

Summary

evaluate the long-term efficacy and safety of oncology between D2 laparoscopic approach distal gastric resection (distal gastrectomy, D2 lymph node dissection) with the current standard surgical treatment model D2 open approach distal gastric resection (distal gastrectomy, D2 lymphadenectomy).

Conditions

  • Locally Advanced Gastric Cancer

Interventions

PROCEDURE

open surgery

Patients in this arm undergo radical resection of gastric cancer in open surgery.Open surgery is a conventional technique for gastric cancer patients.

PROCEDURE

laparoscopic surgery

Patients in this arm undergo radical resection of gastric cancer in laparoscopic surgery.Laparoscopic surgery is a new and minimum invasive technique for gastric cancer patients.

Sponsors & Collaborators

  • Cai Kailin

    lead OTHER

Principal Investigators

  • Guobin Wang, MD,PhD · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  • Kaixiong Tao, MD,PhD · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302794 on ClinicalTrials.gov